Uploaded on Sep 11, 2024
According to the latest research report by IMARC Group, The United States diagnostic imaging market size is projected to exhibit a growth rate (CAGR) of 6.20% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-diagnostic-imaging-market
United States Diagnostic Imaging Market PPT 2024: Size, Growth, Demand and Forecast till 2032
United States Diagnostic
Imaging Market
Research and Forecast
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved
About IMARC Group
IMARC Group is a g lobal management consul t ing f i rm that he lps the wor ld ’s most ambi t ious
changemakers to create a las t ing impact . Across the s ix major cont inents and 100+ count r ies , we
work a longside our bus iness par tners as one team wi th a common ambi t ion to achieve unparal le led
resul ts , gain a compet i t ive edge, and t ransform indust r ies . IMARC Group excels in unders tanding
i ts c l ients ’ bus iness pr ior i t ies and del iver ing ta i lored solut ions that dr ive meaningfu l outcomes. Our
c l ient base spans over 3,000 organizat ions in the pr ivate, publ ic , and soc ia l sectors , ranging f rom
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of market entry and expansion serv ices. Our of fer ings inc lude
thorough market assessment , feas ib i l i ty s tudies, company incorporat ion ass is tance, fac tory setup
suppor t , regulatory approvals and l icens ing navigat ion, branding, market ing and sales st rategies,
compet i t ive landscape and benchmark ing analyses, pr ic ing and cost research, and procurement
research. These serv ices are des igned to ass is t companies in evaluat ing market oppor tuni t ies ,
set t ing up new ent i t ies , navigat ing regulatory landscapes, boost ing brand v is ib i l i ty , analyz ing
compet i tors, and opt imiz ing procurement s t rategies.
A c c o r d i n g t o t h e l a t e s t r e p o r t b y I M A R C G r o u p , t i t l e d " U n i t e d S t a t e s D i a g n o s t i c I m a g i n g
M a r k e t : I n d u s t r y T r e n d s , S h a r e , S i z e , G r o w t h , O p p o r t u n i t y a n d F o r e c a s t 2 0 2 4 -
2 0 3 2 , " t h e U n i t e d S t a t e s d i a g n o s t i c i m a g i n g m a r k e t s i z e i s p r o j e c t e d t o e x h i b i t a g r o w t h r a t e
( C A G R ) o f 6 . 2 0 % d u r i n g 2 0 2 4 - 2 0 3 2 .
C h r o n i c c o n d i t i o n s s u c h a s c a r d i o v a s c u l a r d i s e a s e s , c a n c e r , a n d n e u r o l o g i c a l d i s o r d e r s a r e
Report i n c r e a s i n g l y c o m m o n d u e t o a n a g i n g p o p u l a t i o n a n d l i f e s t y l e - r e l a t e d r i s k f a c t o r s . T h e s e
d i s e a s e s o f t e n r e q u i r e a d v a n c e d i m a g i n g t e c h n i q u e s f o r d i a g n o s i s , m o n i t o r i n g , a n d t r e a t m e n t
p l a n n i n g . D i a g n o s t i c i m a g i n g m o d a l i t i e s l i k e M R I , C T s c a n s , u l t r a s o u n d , a n d P E T s c a n s
Highlight and p r o v i d e d e t a i l e d a n d p r e c i s e i m a g e s , a i d i n g i n t h e e a r l y d e t e c t i o n a n d m a n a g e m e n t o f t h e s e
c o n d i t i o n s .
E a r l y d i a g n o s i s i s c r u c i a l f o r i m p r o v i n g p a t i e n t o u t c o m e s , a s i t a l l o w s f o r t i m e l y i n t e r v e n t i o n
Description a n d m o r e e f f e c t i v e t r e a t m e n t . T h e g r o w i n g e m p h a s i s o n p r e v e n t i v e h e a l t h c a r e a l s o f u e l s t h e
d e m a n d f o r d i a g n o s t i c i m a g i n g , a s r e g u l a r s c r e e n i n g s a n d c h e c k - u p s b e c o m e m o r e p r e v a l e n t .
F u r t h e r m o r e , a d v a n c e m e n t s i n i m a g i n g t e c h n o l o g y , i n c l u d i n g t h e d e v e l o p m e n t o f h i g h -
r e s o l u t i o n a n d 3 D i m a g i n g s y s t e m s , e n h a n c e t h e c a p a b i l i t y t o d i a g n o s e c o m p l e x m e d i c a l
c o n d i t i o n s a c c u r a t e l y , d r i v i n g m a r k e t g r o w t h .
R e q u e s t f o r a P D F s a m p l e o f t h i s r e p o r t :
h t t p s : / / w w w . i m a r c g r o u p . c o m / u n i t e d - s t a t e s - d i a g n o s t i c - i m a g i n g - m a r k e t / r e q u e s t s a m p l e
Report Description
U n i t e d S t a t e s D i a g n o s t ic I m a g i n g Ma r k e t T r e n d s :
T he e x p a n s i o n o f h ea l t h ca r e i n f r a s t r u c t u re an d i n c r e a s i ng h e a l t h ca r e e x p en d i t u re a r e k e y f ac t o r s p r o p e l l i n g t h e d i a g n os t i c
i ma g i n g ma r k e t i n t h e U n i t e d S t a te s . S i g n i f i c a n t i n v e s tm e n ts i n h ea l t h c a r e f a c i l i t i e s , b o t h pu b l i c a nd p r i va t e , h a v e l ed t o t h e
w i de s p r ea d a v a i l a b i l i t y o f a d va n c e d i m a g i n g e q u i pm e n t a c r os s t h e c o un t r y . H o sp i t a l s , d i a g no s t i c c e n t e r s , a n d c l i n i c s a r e
co n t i n ua l l y up g r a d i ng t h e i r i m a g i n g c a p a b i l i t i e s t o o f f e r c u t t i n g - e d g e d i ag n o s t i c s e r v i c e s , t h e r e by a t t r a c t i n g m o r e p a t i e n t s .
T he i n t e g ra t i o n o f a r t i f i c i a l i n t e l l i g e n ce ( A I ) a n d m a c h i ne l e a r n i n g i n d i a g no s t i c i m ag i n g i s a l s o t r a n s f o r m i n g t h e ma r k e t . A I -
d r i v e n i ma g i n g s o l u t i o n s ca n a n a l y ze v a s t am o u n t s o f d a t a q u i c k l y an d a cc u r a t e l y , a ss i s t i n g r a d i o l o g i s t s i n d e t e c t i n g
ab n o r ma l i t i e s an d e n ha n c i n g d i a g n os t i c a cc u r a cy .
T h i s t e c hn o l o g i c a l i n t e g r a t i o n n o t o n l y i m p ro v e s t he e f f i c i en c y o f i m ag i n g p r oc e d u r es b u t a l s o he l p s i n re d u c i n g d i a g n os t i c
e r r o r s . Mo r e o ve r , f av o r a b l e r e i mb u r s e me n t po l i c i e s a nd g o v e rn m en t i n i t i a t i ve s a i me d a t i m p r o v i n g h e a l t h c a r e a c c e ss a n d
qu a l i t y c o n t r i b u t e t o t he m a r k e t ' s g ro w t h . P r o g r a ms l i k e M e d i c a r e a n d M ed i c a i d p r ov i d e c o v e r a g e f o r va r i o u s i m ag i n g
p r o c e d u r e s , m ak i n g t h em m o r e a f f o r d a b l e f o r a l a r g e r s e g m en t o f t h e p op u l a t i o n . T h e g ro w i n g a w a r e n es s a m on g p a t i e n t s
ab o u t t h e be n e f i t s o f e a r l y d i a gn o s i s an d t h e a v a i l ab i l i t y o f a d v a nc e d i ma g i n g t e c hn o l o g i e s f u r t h e r b o o s t t he a do p t i o n o f
d i a g n o s t i c i m ag i n g s e rv i c e s .
V i e w R e p o r t T O C , F i g u r e s a n d T a b l e s : h t t p s : / / w ww . i m a r c g ro u p . co m / u n i t e d - s ta t e s - d i a g n o s t i c - im a g i n g - m a r k e t
Modality Insights:
• MRI
o Low and Mid Fie ld MRI Systems
o High Field MRI Systems
o Very High and Ul tra High Field MRI
Systems
• Computed Tomography
Report o Low-End Scanners
o Mid-Range Scanners
Segmentation o High-End Scanners
• Ultrasound
o 2D Ultrasound
o 3D Ultrasound
o Others
• X-Ray
o Analog Systems
o Digi tal Systems
• Nuclear Imaging
o Positron Emission Tomography (PET)
o Single Photon Emission Computed
Tomography (SPECT)
• Others
Report Application Insights:
• Cardiology
Segmentation • Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Others
End User Insights:
• Hospitals
• Diagnost ic Centers
• Others
Region Insights:
Report • Northeast
Segmentation • Midwest
• South
• West
How has the United States diagnostic imaging market
performed so far and how will it perform in the coming
years?
What has been the impact of COVID-19 on the United States
diagnostic imaging market?
What is the breakup of the United States diagnostic imaging
market on the basis of modality?
Key
What is the breakup of the United States diagnostic imaging
Questions market on the basis of application?
Answered in What is the breakup of the United States diagnostic imaging market on the basis of end user?
the Report What are the various stages in the value chain of the United
States diagnostic imaging market?
What are the key driving factors and challenges in the United
States diagnostic imaging?
What is the structure of the United States diagnostic imaging
market and who are the key players?
What is the degree of competition in the United States
diagnostic imaging market?
1 P r e f a c e
2 S c o p e a n d M e t h o d o l o g y
2 . 1 O b j e c t i v e s o f t h e S t u d y
2 . 2 S t a k e h o l d e r s
2 . 3 D a t a S o u r c e s
2 . 3 . 1 P r i m a r y S o u r c e s
2 . 3 . 2 S e c o n d a r y S o u r c e s
2 . 4 M a r k e t E s t i m a t i o n
Table of 2 . 4 . 1 B o t t o m - U p A p p r o a c h 2 . 4 . 2 T o p - D o w n A p p r o a c h
2 . 5 F o r e c a s t i n g M e t h o d o l o g y
3 E x e c u t i v e S u m m a r y
4 U n i t e d S t a t e s D i a g n o s t i c I m a g i n g M a r k e t - I n t r o d u c t i o n
Contents 4 . 1 O v e r v i e w 4 . 2 M a r k e t D y n a m i c s
4 . 3 I n d u s t r y T r e n d s
4 . 4 C o m p e t i t i v e I n t e l l i g e n c e
5 U n i t e d S t a t e s D i a g n o s t i c I m a g i n g M a r k e t L a n d s c a p e
5 . 1 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
5 . 2 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 U n i t e d S t a t e s D i a g n o s t i c I m a g i n g M a r k e t - B r e a k u p b y M o d a l i t y
6 . 1 M R I
6 . 1 . 1 O v e r v i e w
6 . 1 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 1 . 3 M a r k e t S e g m e n t a t i o n
6 . 1 . 3 . 1 L o w a n d M i d F i e l d M R I S y s t e m s
6 . 1 . 3 . 2 H i g h F i e l d M R I S y s t e m s
6 . 1 . 3 . 3 V e r y H i g h a n d U l t r a H i g h F i e l d M R I S y s t e m s
6 . 1 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 2 C o mp u t e d T o m o g r a p h y
6 . 2 . 1 O v e r v i e w
6 . 2 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 2 . 3 M a r k e t S e g m e n ta t i o n
6 . 2 . 3 . 1 L o w - E n d S c a n n e r s
6 . 2 . 3 . 2 M i d - R a n g e S c a n n e r s
6 . 2 . 3 . 3 H i g h - E n d S c a n n e r s
6 . 2 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 3 U l t r a s o u n d
6 . 3 . 1 O v e r v i e w
Table of 6 . 3 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 ) 6 . 3 . 3 M a r k e t S e g m e n ta t i o n
6 . 3 . 3 . 1 2 D U l t r a s o u n d
Contents 6 . 3 . 3 . 2 3 D U l t r a s o u n d 6 . 3 . 3 . 3 O th e r s
6 . 3 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 4 X - R a y
6 . 4 . 1 O v e r v i e w
6 . 4 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 4 . 3 M a r k e t S e g m e n ta t i o n
6 . 4 . 3 . 1 A n a l o g S y s t e m s
6 . 4 . 3 . 2 D i g i t a l S y s t e m s
6 . 4 . 4 M a r k e t F o r e c a s t ( 2 0 2 4 - 2 0 3 2 )
6 . 5 N u c l e a r Im a g i n g
6 . 5 . 1 O v e r v i e w
6 . 5 . 2 H i s t o r i c a l a n d C u r r e n t M a r k e t T r e n d s ( 2 0 1 8 - 2 0 2 3 )
6 . 5 . 3 M a r k e t S e g m e n ta t i o n
F o r m o r e i n f o r m a t io n , v i s i t :
ht tps : / /www. imarcgroup .com/un i ted-s ta tes -d iagnos t i c - imag i
ng -market / toc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024 IMARC Al l R ights Reserved
Th is Pub l i ca t ion and a l l i t ’ s con ten ts un less o therw ise men t i oned a re copy r i gh ted in the name o f
I n t e rna t i ona l Marke t Ana lys i s Research and Consu l t ing ( IMARC) . No pa r t o f t h i s pub l i ca t ion may be
rep roduced , repackaged , red i s t r i bu ted o r res o ld i n who le o r i n any pa r t . The pub l i ca t ion may a l so
no t be used i n any f o rm o r by and means g raph i c e lec t ron ic o r mechan ic a l , i nc lud ing pho tocopy ing ,
reco rd ing , t ap ing o r by i n fo rmat i on s to rage o r re t r ieva l , o r by any o the r f o rm, w i t hou t the exp ress
c ons en t o f I n t e rna t iona l Marke t Ana lys i s Research and Consu l t i ng ( IMARC) .
Disc la imer : Al l con ten ts and da ta o f t h i s pub l i c a t i on , i nc lud ing fo recas t s , da ta ana lys i s and op in ion
have been based on in f o rmat ion and sources be l ieved to be accu ra te and re l iab le a t t he t ime o f
pub l i sh ing . In t e rna t i ona l Ma rke t Ana l ys is Research and Consu l t ing makes no rep resen ta t ion o f
war ran t y o f any k ind as to t he acc u racy o r comp le teness o f any I n fo rmat i on p rov ided . IMARC
accep ts no l i ab i l i t y wha tsoever f o r any los s o r damage resu l t i ng f rom op in ion , e r ro rs o r
i naccu rac ies i f any f ound th is pub l i ca t ion .
IMARC, IMARC Group and G loba l Therapy I ns igh t Ser i es a re reg is t e red t rademarks o f I n te rna t iona l
Marke t Ana lys i s Research and Consu l t ing . A l l o the r t rademarks used i n th i s pub l i ca t i on a re
reg i s te red t rademarks o f t he i r r espec t i ve compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us:
Comments